Implications for blinding in clinical trials with THC-containing cannabinoids based on the CANNA-TICS trial

Randomized double-blind placebo-controlled trials (RCTs) are regarded as the gold standard for clinical trials. While there are established standards to avoid unblinding, in RCTs using tetrahydrocannabinol (THC) containing cannabinoids, however, accidental unblinding and intentional self-unbinding m...

Descripción completa

Detalles Bibliográficos
Autores principales: Müller-Vahl, Kirsten R., Jakubovski, Ewgeni, Fremer, Carolin, Lenz-Ziegenbein, Martina, Großhennig, Anika, Klages, Carolin, Koch, Armin, Haas, Martina, Pisarenko, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9533554/
https://www.ncbi.nlm.nih.gov/pubmed/36213751
http://dx.doi.org/10.3389/fnins.2022.793703

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9533554/
https://www.ncbi.nlm.nih.gov/pubmed/36213751
http://dx.doi.org/10.3389/fnins.2022.793703

Ejemplares similares